Enzo Biochem, Inc. reported earnings results for the full year ended July 31, 2023. For the full year, the company reported sales was USD 31.06 million compared to USD 32.64 million a year ago. Net income was USD 20.29 million compared to net loss of USD 18.26 million a year ago.

Basic loss per share from continuing operations was USD 0.51 compared to USD 0.42 a year ago. Diluted loss per share from continuing operations was USD 0.51 compared to USD 0.42 a year ago. Basic earnings per share was USD 0.41 compared to basic loss per share of USD 0.38 a year ago.

Diluted earnings per share was USD 0.41 compared to diluted loss per share of USD 0.38 a year ago.